Feedback / Questions
siroquine (JP001) - Johnpro Biotech
https://www.prnewswire.com/news-releases/hebabiz-biotechs-anti-cancer-drug-candidate-under-development-siroquine-jp001-has-been-approved-for-ind-clinical-trials-in-the-united-states-301359646.html
Aug 20, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next